PREPARATION AND USE OF BICYCLIC HIMBACINE DERIVATIVES AS PAR-RECEPTOR ANTAGONISTS
- Application ID: EP13757283
- Status: █ The patent has been granted
This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Merck & Co. Inc. and Merck Sharp & Dohme Ltd. are specialized in A61. Merck & Co. Inc., Merck Sharp & Dohme Ltd. is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.
- 06.03.2012 - Priority Date (US 201261607062P)
- 12.09.2013 - Publication A1 (WO2013134012)
- 14.01.2015 - Publication A1 (EP2822557)
- 23.08.2017 - Publication B1 (EP2822557)